Cargando…
Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas technology is a molecular tool specific to sequences for engineering genomes. Among diverse clusters of Cas proteins, the class 2/type II CRISPR/Cas9 system, despite several challenges, such as off-target effects, editing eff...
Autores principales: | Alinejad, Tahereh, Modarressi, Shabnam, Sadri, Zahra, Hao, Zuo, Chen, Cheng Shui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423114/ https://www.ncbi.nlm.nih.gov/pubmed/37222810 http://dx.doi.org/10.1007/s00432-023-04747-6 |
Ejemplares similares
-
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
por: You, Liting, et al.
Publicado: (2019) -
CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
por: Ebrahimi, Saeedeh, et al.
Publicado: (2022) -
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy
por: Guo, Ning, et al.
Publicado: (2021) -
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016) -
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2023)